Institutional investors purchased a net $6.2 million shares of NWBO during the quarter ended September 2015. This may signal that the smart money is gaining interest in this company as the 41.36% of the shares outstanding that institutional investors hold is among the lowest in the Biotechnology industry.
Mutual fund holders
Largest Quarterly Institutional Transactions
Latest Institutional Activity
WOODFORD INVESTMENT MANAGEMENT L... Bought 5.5 Million shares of Northwest Biotherapeutics...